Calvert Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-46,482
Closed -$5.38M 779
2016
Q4
$5.38M Sell
46,482
-1,506
-3% -$168K 0.2% 147
2016
Q3
$5.02M Buy
47,988
+2,522
+6% +$273K 0.18% 167
2016
Q2
$4.48M Buy
45,466
+1,038
+2% +$107K 0.18% 139
2016
Q1
$4.45M Buy
44,428
+1,339
+3% +$138K 0.2% 105
2015
Q4
$5.16M Buy
43,089
+7,365
+21% +$852K 0.24% 83
2015
Q3
$3.86M Buy
35,724
+1,448
+4% +$180K 0.19% 116
2015
Q2
$3.97M Buy
+34,276
New +$3.92M 0.18% 121

Other funds holding CELG

Calvert Investment Management's CELG Position: Q1 2017 in Review

Calvert Investment Management sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 46,482 shares — an estimated $5.38M sold.

Calvert Investment Management first reported a position in CELG in Q2 2015 and held it in 7 quarters. The position peaked at $5.38M in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Calvert Investment Management reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 46,482 Celgene Corp shares in Q1 2017, an estimated $5.38M.
  • Calvert Investment Management first reported a position in Celgene Corp in Q2 2015 and held it in 7 quarters.
  • Calvert Investment Management's Celgene Corp position peaked at $5.38M in Q4 2016.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.